JPY 2584.0
(1.1%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 8.2 Billion JPY | 3.24% |
2022 | 7.94 Billion JPY | 0.98% |
2021 | 7.86 Billion JPY | 13.09% |
2020 | 6.95 Billion JPY | -8.68% |
2019 | 7.61 Billion JPY | 2.5% |
2018 | 7.43 Billion JPY | -9.6% |
2017 | 8.22 Billion JPY | 3.34% |
2016 | 7.95 Billion JPY | -7.89% |
2015 | 8.63 Billion JPY | -13.66% |
2014 | 10 Billion JPY | -3.62% |
2013 | 10.38 Billion JPY | -7.57% |
2012 | 11.23 Billion JPY | -0.14% |
2011 | 11.24 Billion JPY | -5.48% |
2010 | 11.89 Billion JPY | -1.63% |
2009 | 12.09 Billion JPY | -4.47% |
2008 | 12.66 Billion JPY | -5.05% |
2007 | 13.33 Billion JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 8.08 Billion JPY | -2.93% |
2024 Q1 | 8.33 Billion JPY | 1.59% |
2023 Q2 | 7.97 Billion JPY | -5.66% |
2023 Q1 | 8.45 Billion JPY | 6.36% |
2023 FY | 8.2 Billion JPY | 3.24% |
2023 Q3 | 7.78 Billion JPY | -2.4% |
2023 Q4 | 8.2 Billion JPY | 5.41% |
2022 Q4 | 7.94 Billion JPY | 5.78% |
2022 Q3 | 7.51 Billion JPY | -1.12% |
2022 Q2 | 7.59 Billion JPY | -5.32% |
2022 Q1 | 8.02 Billion JPY | 1.98% |
2022 FY | 7.94 Billion JPY | 0.98% |
2021 Q3 | 6.95 Billion JPY | -0.26% |
2021 FY | 7.86 Billion JPY | 13.09% |
2021 Q2 | 6.97 Billion JPY | -3.04% |
2021 Q1 | 7.18 Billion JPY | 3.32% |
2021 Q4 | 7.86 Billion JPY | 13.18% |
2020 Q3 | 6.75 Billion JPY | -1.3% |
2020 Q4 | 6.95 Billion JPY | 2.98% |
2020 Q1 | 7.26 Billion JPY | -4.63% |
2020 Q2 | 6.84 Billion JPY | -5.79% |
2020 FY | 6.95 Billion JPY | -8.68% |
2019 FY | 7.61 Billion JPY | 2.5% |
2019 Q1 | 7.77 Billion JPY | 4.59% |
2019 Q2 | 7.26 Billion JPY | -6.51% |
2019 Q4 | 7.61 Billion JPY | 10.49% |
2019 Q3 | 6.89 Billion JPY | -5.13% |
2018 Q2 | 7.48 Billion JPY | -7.51% |
2018 FY | 7.43 Billion JPY | -9.6% |
2018 Q4 | 7.43 Billion JPY | 6.83% |
2018 Q1 | 8.09 Billion JPY | -1.58% |
2018 Q3 | 6.95 Billion JPY | -7.05% |
2017 Q4 | 8.22 Billion JPY | 11.77% |
2017 FY | 8.22 Billion JPY | 3.34% |
2017 Q3 | 7.35 Billion JPY | -5.36% |
2017 Q2 | 7.77 Billion JPY | -4.43% |
2017 Q1 | 8.13 Billion JPY | 2.21% |
2016 Q2 | 8.09 Billion JPY | -5.42% |
2016 Q4 | 7.95 Billion JPY | 2.69% |
2016 Q1 | 8.55 Billion JPY | -0.95% |
2016 FY | 7.95 Billion JPY | -7.89% |
2016 Q3 | 7.74 Billion JPY | -4.25% |
2015 Q4 | 8.63 Billion JPY | 4.27% |
2015 FY | 8.63 Billion JPY | -13.66% |
2015 Q3 | 8.28 Billion JPY | -6.66% |
2015 Q2 | 8.87 Billion JPY | -10.13% |
2015 Q1 | 9.87 Billion JPY | -1.3% |
2014 Q3 | 9.57 Billion JPY | -7.47% |
2014 Q4 | 10 Billion JPY | 4.49% |
2014 FY | 10 Billion JPY | -3.62% |
2014 Q1 | 11.23 Billion JPY | 8.27% |
2014 Q2 | 10.34 Billion JPY | -7.93% |
2013 Q3 | 9.76 Billion JPY | -5.48% |
2013 Q4 | 10.38 Billion JPY | 6.27% |
2013 FY | 10.38 Billion JPY | -7.57% |
2013 Q1 | 11.12 Billion JPY | -0.92% |
2013 Q2 | 10.33 Billion JPY | -7.12% |
2012 Q1 | 11.18 Billion JPY | -0.6% |
2012 Q4 | 11.23 Billion JPY | 13.73% |
2012 FY | 11.23 Billion JPY | -0.14% |
2012 Q3 | 9.87 Billion JPY | -4.39% |
2012 Q2 | 10.32 Billion JPY | -7.61% |
2011 Q4 | 11.24 Billion JPY | 8.27% |
2011 Q2 | 10.91 Billion JPY | -6.6% |
2011 Q3 | 10.38 Billion JPY | -4.86% |
2011 FY | 11.24 Billion JPY | -5.48% |
2011 Q1 | 11.68 Billion JPY | -1.76% |
2010 Q1 | 11.93 Billion JPY | -1.32% |
2010 Q2 | 11.65 Billion JPY | -2.33% |
2010 Q3 | 11.29 Billion JPY | -3.15% |
2010 Q4 | 11.89 Billion JPY | 5.39% |
2010 FY | 11.89 Billion JPY | -1.63% |
2009 Q3 | 11.24 Billion JPY | -0.14% |
2009 Q4 | 12.09 Billion JPY | 7.6% |
2009 Q2 | 11.25 Billion JPY | 0.0% |
2009 FY | 12.09 Billion JPY | -4.47% |
2008 FY | 12.66 Billion JPY | -5.05% |
2008 Q4 | 12.66 Billion JPY | 2.42% |
2008 Q3 | 12.36 Billion JPY | 0.0% |
2007 FY | 13.33 Billion JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
DVx Inc. | 13.48 Billion JPY | 39.153% |
Seikagaku Corporation | 11.3 Billion JPY | 27.471% |
Eiken Chemical Co., Ltd. | 15.67 Billion JPY | 47.686% |
Create Medic Co., Ltd. | 4.31 Billion JPY | -90.115% |
PHC Holdings Corporation | 425.15 Billion JPY | 98.071% |
Techno Medica Co., Ltd. | 3.61 Billion JPY | -126.879% |
Nihon Kohden Corporation | 52.14 Billion JPY | 84.271% |
Fukuda Denshi Co., Ltd. | 42.46 Billion JPY | 80.686% |
Japan Lifeline Co., Ltd. | 15.58 Billion JPY | 47.354% |
Japan Medical Dynamic Marketing, INC. | 5.88 Billion JPY | -39.447% |
3-D Matrix, Ltd. | 5.53 Billion JPY | -48.244% |
CYBERDYNE Inc. | 9.52 Billion JPY | 13.868% |